-
公开(公告)号:US20110092703A1
公开(公告)日:2011-04-21
申请号:US12672818
申请日:2008-08-08
申请人: Shogo Sakuma , Tsuyoshi Endo , Noriko Kanakubo , Masahiko Arai , Toshihiro Takahashi , Toshiyasu Imai , Kumiko Taguchi , Eriko Nakata , Nobutaka Mochiduki , Masatoshi Ushioda , Makoto Tsuda , Kazuhide Inoue
发明人: Shogo Sakuma , Tsuyoshi Endo , Noriko Kanakubo , Masahiko Arai , Toshihiro Takahashi , Toshiyasu Imai , Kumiko Taguchi , Eriko Nakata , Nobutaka Mochiduki , Masatoshi Ushioda , Makoto Tsuda , Kazuhide Inoue
IPC分类号: C07D241/04
CPC分类号: A61K31/495 , A61K31/496 , C07D241/04 , C07D405/12
摘要: A P2X4 receptor antagonist is a compound represented by the formula (I) or a pharmacologically acceptable salt thereof, which is used as a preventive or therapeutic agent for neuropathic pains: Wherein B is aryl or the like that can have a substituent; Y is C1-5 alkylene that can have a double bond; Z is O, S or the like; each of R1, R2 and R3 independently is hydrogen, C1-8 alkyl or the like; R4 is hydrogen, C1-8 alkyl or the like; each of P and Q independently is hydrogen, halogen, C1-8 alkyl or the like; W is C1-8 alkyl or the like; and each of n and m independently is 1 or 2.
摘要翻译: P2X4受体拮抗剂是由式(I)表示的化合物或其药理学上可接受的盐,其用作神经性疼痛的预防或治疗剂:其中B是可以具有取代基的芳基等; Y是可具有双键的C 1-5亚烷基; Z是O,S等; R 1,R 2和R 3各自独立地为氢,C 1-8烷基等; R4是氢,C1-8烷基等; P和Q各自独立地是氢,卤素,C 1-8烷基等; W是C 1-8烷基等; n和m各自独立地为1或2。
-
公开(公告)号:US08952030B2
公开(公告)日:2015-02-10
申请号:US14343218
申请日:2012-09-07
IPC分类号: A61K31/485 , C07D491/18 , C07D487/08 , C07F7/18
CPC分类号: C07D491/18 , C07D471/08 , C07D471/22 , C07D487/08 , C07D491/22 , C07F7/1804
摘要: A morphinan derivative represented by the following general formula (I): (in the formula, R1 represents hydrogen, C1-6 alkyl, cycloalkylalkyl (the cycloalkyl moiety has 3 to 6 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms), aralkyl (the aryl moiety has 6 to 10 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms) and the like, R2 represents hydrogen, C1-6 alkyl, C3-6 cycloalkyl, C6-10 aryl, aralkyl (the aryl moiety has 6 to 10 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms) and the like, R3, R4 and R5 represent hydrogen, hydroxy, carbamoyl, C1-6 alkoxy, C6-10 aryloxy and the like, R6a, R6b, R7, R8, R9, and R10 represent hydrogen and the like, X represents O or CH2, and Y represents C═O, SO2, an atomic bond and the like), or an acid addition salt thereof is used as an analgesic.
摘要翻译: 由以下通式(I)表示的吗啡喃衍生物:(式中,R 1表示氢,C 1-6烷基,环烷基烷基(环烷基部分具有3〜6个碳原子,亚烷基部分具有1〜5个碳原子) ,芳烷基(芳基部分具有6〜10个碳原子,亚烷基部分具有1〜5个碳原子)等,R 2表示氢,C 1-6烷基,C 3-6环烷基,C 6-10芳基,芳烷基( 芳基部分具有6至10个碳原子,亚烷基部分具有1至5个碳原子)等,R 3,R 4和R 5表示氢,羟基,氨基甲酰基,C 1-6烷氧基,C 6-10芳氧基等,R 6a ,R6b,R7,R8,R9和R10表示氢等,X表示O或CH2,Y表示C = O,SO2,原子键等)或其酸加成盐作为 镇痛药
-
公开(公告)号:US20140343015A1
公开(公告)日:2014-11-20
申请号:US14343218
申请日:2012-09-07
IPC分类号: C07D491/18 , C07F7/18 , C07D487/08
CPC分类号: C07D491/18 , C07D471/08 , C07D471/22 , C07D487/08 , C07D491/22 , C07F7/1804
摘要: A morphinan derivative represented by the following general formula (I) (in the formula, R1 represents hydrogen, C1-6 alkyl, cycloalkylalkyl (the cycloalkyl moiety has 3 to 6 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms), aralkyl (the aryl moiety has 6 to 10 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms) and the like,R2 represents hydrogen, C1-6 alkyl, C3-6 cycloalkyl, C6-10 aryl, aralkyl (the aryl moiety has 6 to 10 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms) and the like,R3, R4 and R5 represent hydrogen, hydroxy, carbamoyl, C1-6 alkoxy, C6-10 aryloxy and the like,R6a, R6b, R7, R8, R9, and R10 represent hydrogen and the like,X represents O or CH2, andY represents C═O, SO2, an atomic bond and the like), or an acid addition salt thereof is used as an analgesic.
摘要翻译: 由以下通式(I)表示的吗啡喃衍生物(式中,R 1表示氢,C 1-6烷基,环烷基烷基(环烷基部分具有3〜6个碳原子,亚烷基部分具有1〜5个碳原子) 芳烷基(芳基部分具有6至10个碳原子,亚烷基部分具有1至5个碳原子)等,R 2表示氢,C 1-6烷基,C 3-6环烷基,C 6-10芳基,芳烷基(芳基 部分具有6至10个碳原子,并且亚烷基部分具有1至5个碳原子)等,R3,R4和R5表示氢,羟基,氨基甲酰基,C1-6烷氧基,C6-10芳氧基等,R6a, R6b,R7,R8,R9和R10表示氢等,X表示O或CH2,Y表示C = O,SO2,原子键等)或其酸加成盐作为止痛剂 。
-
-